Skip to main content
Clinical Trials/NCT04490473
NCT04490473UnknownNot Applicable

Turkish Validity And Reliability of the SARS-CoV-2 Anxiety Scale

DILEK SAYIK1 site in 1 country300 target enrollmentStarted: July 24, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
Anxiety in SARS-CoV-2

Study Overview

Brief Summary

The coronavirus outbreak has adversely affected individuals in the community, as in the rest of the world. However, in order to carry out this epidemic period in a healthy and conscious manner, determining the anxiety levels of individuals in the society and supporting them psychologically is of great importance. In order to achieve this, healthcare professionals working clinically or academically have important duties. This study was planned to test its validity and reliability in order to adapt the Coronavirus Anxiety Scale to Turkish.

Detailed Description

Coronaviruses can be seen in animals and humans as infections that can be mild and severe in society. The SARS-CoV-2 virus, a type of coronavirus, started in China in December 2019 and has spread worldwide as of January 2020. The absence of vaccine and treatment for SARS-CoV-2 disease threatens health worldwide and significantly affects people's daily routine. In China, where the pandemic started, shopping malls and schools were closed for a while, and city entrances and exits were stopped for a while. Although there are similar practices in excellence, as in many countries, measures such as curfew, nursery and school closure continue to be taken for under-20s and over-65s. . The coronavirus epidemic that affects our entire life is not fully known about the disease process, WHO is defined as the pandemic of the epidemic, the nearest contact is the greatest risk of transmission, and the loss of many lives during this process affects all individuals in the society negatively and increases the level of anxiety .

It is a psychological reaction involving many emotions such as anxiety, stress, or anxiety, fear and distress that arise in a situation that threatens the safety of the individual. Conditions such as uncertainty, various diseases (cancer, epidemic, etc.) and losing a relative can cause anxiety. Outbreaks that occur suddenly and are at risk of death are among these reasons.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • individuals agree to participate in the study
  • 18 years old,
  • Lack of visual obstacle,
  • Knowing how to speak, read and write in Turkish.

Exclusion Criteria

  • individuals refuse to participate in the study
  • 18 years old,
  • Visually impaired,
  • Does not know how to speak, read and write in Turkish

Outcomes

Primary Outcomes

Anxiety in SARS-CoV-2

Time Frame: 4 weeks

anxiety increase in SARS-CoV-2 in humans.

Ratio of SARS-CoV-2 anxiety scale to beck anxiety scale

Time Frame: 4 weeks

The ratio of SARS-CoV-2 anxiety scale to beck anxiety scale is similar.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
DILEK SAYIK
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

DILEK SAYIK

Principal Investigator

Eskisehir Osmangazi University

Study Sites (1)

Loading locations...

Similar Trials